White House speeds monkeypox vaccines, but not everyone likes the pace


Comment

White House officials on Thursday took steps to expand access to monkeypox vaccines, including a deal to eliminate 2.5 million vials in the United States. Although some local health officials applauded the move, others were increasingly panicked. The plan is to increase existing supplies by splitting vaccine doses into fifths, for more time to examine data and to train providers to accurately deliver shots.

A local health official said the Biden administration is “forcing our hands”. Officials, who spoke on condition of anonymity because they did not want to jeopardize vaccine orders. “It’s extraordinarily frustrating because we have to execute and defend this strategy… it’s a question of giving us the time and dose to execute that strategy.”

A team of researchers also urged officials to tweak Plan, Having said that there was little data on its effectiveness.

“We propose a mixed-dose strategy,” where all recipients will receive one shot in origin, and the second shot through the new approach, researchers from the Rapid Epidemiological Study of Prevalence, Networks and Demography of Monkeypox Infection said in a report. was written in the letter. New York and federal officials shared with The Washington Post.

The debate over vaccination strategy comes as health officials are rushing to vaccinate more than 1.6 million high-risk Americans against a virus that has sickened more than 14,100 people and often resulted in severe pain and other complications. There is no confirmation in this country. There have been a large number of reported cases among gay and bisexual men, who are preferred for vaccination.

Administration officials have said they are moving to secure more vaccine doses, after criticism they failed to obtain adequate supplies earlier in the outbreak. On Thursday he and Danish vaccine maker Bavarian Nordic Announced a deal to accelerate to 2.5 million vials by transferring some production to Grand River Aseptic Manufacturing, a Michigan-based company. The first finished dose is expected later this year.

“This partnership between Bavarian Nordic and GRAM will significantly increase the ability to fill and dismantle government-owned supplements – a first in the United States – and allow us to more quickly expand our current and future supplies to locations nationwide. will allow us to distribute it,” White House Monkeypox coordinator Bob Fenton said in a statement.

See also  World’s largest meat supplier shuts two plants — and it’s bad news for beef lovers

Inside America’s monkeypox crisis – and the mistakes that made it worse

Biden officials on Monday also sought to persuade critics of the vaccine-split plan by announcing an additional 1.8 million doses for orders — if local leaders were to split each single-use vial into five and place them under the top layer. Injecting strategy adopted. of the skin, known as intradermal vaccination.

Federal officials have said the new approach will maximize the dose available and is a safer alternative to the traditional method of applying doses to the fatty tissue under the skin, known as subcutaneous vaccination. The Food and Drug Administration last week authorized a change in vaccination strategy, citing a 2015 study on its effectiveness.

“We are really moving to get all the jurisdiction for intradermal dosing,” said Rochelle Valensky, director of the Centers for Disease Control and Prevention, adding that her agency is already working to educate providers on the new approach. was working.

Some local officials enthusiastically embraced the new vaccine strategy, saying it has allowed them to increase limited supplies.

“It’s the only way we can get enough vaccines for people to end this outbreak,” said David Holland, chief clinical officer for the Fulton County Board of Health. in Georgia. Holland said he trusts the science behind the strategy, and health officials in his county, which includes Atlanta, have so far used the approach to vaccinate more than 800 people.

St. CEO Jim Mangia said, “There is a shortage of vaccines, so the idea of ​​being able to get five doses from a vial instead of one, which is what we’re seeing for vaccines, is very appealing, given the huge demand.” was.” John’s Community Health in Los Angeles, which primarily serves African American and Latino populations.

Mangia said his staff “mobilized immediately” after the FDA authorized the new approach on Tuesday, conducted a 7 a.m. training Wednesday morning for employees and vaccinated more than 300 people with the method later that day. “I think using intradermal is a great way to get more people vaccinated,” he said.

See also  Now that everyone’s a Knicks fan, this is what you need to wear

But many other officials are asking for more time to prepare, with the Association of State and Territorial Health Officers’ chief medical officer Marcus Plesia saying he was on call with state and local officials who are pressing federal leaders for more data. Were. Strategy safety and effectiveness.

“I think the states needed a little more time to change that and make sure they have things in place so that they can be successful,” Plesia said.

Officials such as New Orleans’ top public health official, Jennifer Avegno, also questioned the White House’s announcement that 1.8 million doses would become available next week, without acknowledging that they had drastically cut the number of vials. She said her city was prepared for a much lower dose than expected because federal officials had informed that its allocation would be one-fifth of what was planned because an additional four doses could be obtained from each vial under the new injection method. Huh.

Philadelphia’s health commissioner said earlier this week that federal officials had also cut their city’s planned vaccine allocation — from 3,612 single-dose vials to 720 vials.

“We are advocating for our federal partners to reconsider and restore Philadelphia’s allocation of vaccines, which are urgently needed,” Philadelphia Health Commissioner Cheryl Bettygole said in a statement Tuesday. New vaccine strategy. “It’s far from ideal in the middle of an outbreak.”

Patrick Ashley, the DC health officer leading the monkeypox response, voiced similar complaints, saying the city has had difficulty planning a vaccine rollout as the federal government keeps changing its distribution strategy.

The district announced last week that it was expanding vaccine eligibility to include nonresidents and heterosexuals as officials expected 12,000 vials that could provide 60,000 doses. But then its allocation was reduced to one-fifth of the original allocation.

The city was already mobilizing in its public health system to train all nurses to administer shots intravenously, in hopes it could vaccinate thousands of additional people. “That’s the time, energy, and money we could have devoted those resources elsewhere because we were expecting the vaccine to suddenly arrive,” Ashley said.

Biden administration officials separately announced a vaccination program targeted at people attending large LGBTQ events, saying they would set aside 50,000 doses in a pilot initiative to cover high-risk individuals.

See also  Exclusive | Inside the wackiest Knicks watch parties as they staged jaw-dropping Game 4 comeback

Louisiana Heath officials welcomed the arrival of more vaccines early next month for their Southern fall festivities, which were expected to attract thousands of gay men. But he said he has been alarming federal officials since the early weeks of the outbreak and that better protection would have been provided if more vaccines had been able to come out in mid-July.

“We still haven’t been able to offer a pre-exposure vaccine to everyone at risk,” Joe Kantor, Louisiana’s top public health official, told The Washington Post earlier this month. “And the longer we wait on that, the bigger the at-risk population will grow. We really have this window of opportunity that’s closing as we speak.”

Cantor described Thursday’s announcement as “welcome news” but said Louisiana officials are waiting to hear how many additional doses he will receive.

“We need to take every opportunity to be proactive in this outbreak rather than reactive,” he said.

Meanwhile, Biden administration officials said they are working with Bavarian Nordic on additional strategies to help them increase their production capacity.

“They’re a small manufacturer,” Don O’Connell, head of the Strategic Preparedness and Response Administration, which oversees the national stockpile of vaccines, said at a news briefing Thursday. O’Connell said the administration was working with Bavarian Nordic on additional manufacturing capacity addition, such as “working with a potentially larger pharmaceutical company.”

Administration officials have approached vaccine makers such as Pfizer and Merck to partner with Bavarian Nordic because they were not authorized to comment, according to two people who spoke on condition of anonymity.



(This story has not been edited by seemayo staff and is published from a rss feed)

Leave a Comment